515 related articles for article (PubMed ID: 28465641)
1. Clinical characteristics of peptic ulcer perforation in Korea.
Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
[TBL] [Abstract][Full Text] [Related]
2. Is perforated marginal ulcer after the surgery of gastroduodenal ulcer associated with inadequate treatment for Helicobacter pylori eradication?
Aydinli B; Yilmaz O; Ozturk G; Yildigan MI; Gursan N; Basoglu M
Langenbecks Arch Surg; 2007 Sep; 392(5):593-9. PubMed ID: 17370084
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Helicobacter pylori infection in peptic ulcer perforations.
Metzger J; Styger S; Sieber C; von Flüe M; Vogelbach P; Harder F
Swiss Med Wkly; 2001 Feb; 131(7-8):99-103. PubMed ID: 11416885
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
8. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
[TBL] [Abstract][Full Text] [Related]
9. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
10. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.
Kuyvenhoven JP; Veenendaal RA; Vandenbroucke JP
Scand J Gastroenterol; 1999 Nov; 34(11):1082-6. PubMed ID: 10582757
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aspirin and comorbidities are significantly related to bleeding peptic ulcers in elderly patients compared with nonelderly patients in Japan.
Higuchi T; Iwakiri R; Hara M; Shimoda R; Sakata Y; Nakayama A; Nio K; Yamaguchi S; Yamaguchi D; Watanabe A; Akutagawa T; Sakata H; Fujimoto K
Intern Med; 2014; 53(5):367-73. PubMed ID: 24583422
[TBL] [Abstract][Full Text] [Related]
12. Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes.
Quan S; Frolkis A; Milne K; Molodecky N; Yang H; Dixon E; Ball CG; Myers RP; Ghosh S; Hilsden R; van Zanten SV; Kaplan GG
World J Gastroenterol; 2014 Dec; 20(46):17568-77. PubMed ID: 25516672
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
[TBL] [Abstract][Full Text] [Related]
14. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches.
Di Carlo I; Toro A; Sparatore F; Primo S; Barbagallo F; Di Blasi M
Minerva Chir; 2006 Aug; 61(4):325-32. PubMed ID: 17122765
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of perforated duodenal ulcer: the changing scene.
Plummer JM; McFarlane ME; Newnham
West Indian Med J; 2004 Dec; 53(6):378-81. PubMed ID: 15816264
[TBL] [Abstract][Full Text] [Related]
16. Perforated peptic ulcer in children: a 20-year experience.
Hua MC; Kong MS; Lai MW; Luo CC
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):71-4. PubMed ID: 17592367
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding.
Wu CY; Poon SK; Chen GH; Chang CS; Yeh HZ
Scand J Gastroenterol; 1999 Mar; 34(3):234-7. PubMed ID: 10232865
[TBL] [Abstract][Full Text] [Related]
18. Association between ulcer site and outcome in complicated peptic ulcer disease: a Danish nationwide cohort study.
Lolle I; Møller MH; Rosenstock SJ
Scand J Gastroenterol; 2016 Oct; 51(10):1165-71. PubMed ID: 27248208
[TBL] [Abstract][Full Text] [Related]
19. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
20. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease.
Zapata-Colindres JC; Zepeda-Gómez S; Montaño-Loza A; Vázquez-Ballesteros E; de Jesús Villalobos J; Valdovinos-Andraca F
Can J Gastroenterol; 2006 Apr; 20(4):277-80. PubMed ID: 16609757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
